Hiro Tatetsu

9PUBLICATIONS
11CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 20, 2026
Timing of autologous stem cell transplantation and induction response in central nervous system lymphoma.

|Nov 27, 2025
Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.

Taichi Hirano, Hiro Tatetsu, Shikiko Ueno

|Oct 23, 2025
Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphoma.

Takafumi Shichijo, Hiro Tatetsu, Yusuke Higuchi

|Oct 21, 2025
Peripheral T cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy.

Hiro Tatetsu, Koji Kato, Atsushi Wada

|Sep 25, 2024
Decreased PU.1 expression in mature B cells induces lymphomagenesis.

Shinya Endo, Nao Nishimura, Kosuke Toyoda

|Jul 18, 2022
Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphoma.

Takafumi Shichijo, Hiro Tatetsu, Kisato Nosaka

Pageof 2

Frequent Collaborators

5 joint publications

Takafumi Shichijo

4 joint publications

Kisato Nosaka

4 joint publications

Kosuke Toyoda

4 joint publications

Jun-Ichirou Yasunaga